Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28816 | 1.00 | TSHR (0.40) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL28815 | 1.00 | TSHR (0.40) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL637960 | 0.74 | LDHA (0.33) | LDHALDHBACHE | |
| SCHEMBL13176449 | 0.74 | LDHA (0.33) | LDHALDHBACHE | |
| SCHEMBL14784817 | 0.74 | LDHA (0.33) | LDHALDHBACHE | |
| SCHEMBL28895629 | 0.74 | — | — | |
| SCHEMBL454524 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL529628 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL19379407 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 | |
| SCHEMBL454525 | 0.72 | TSHR (0.44) | TSHRTP53EGLN1EGLN3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658402-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | Centre National de la Recherche Scientifique (FR) | 2025-12-10 | — | — | EP | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2024160984-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-08-08 | — | — | WO | claimed |
| EP-4410419-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | Centre National de la Recherche Scientifique (FR) | 2024-08-07 | — | — | EP | claimed |
| WO-2023114656-A1 | METHODS FOR TREATING AND PREVENTING DISEASES AND DISORDER THROUGH MODULATION OF NAD | MARK PAUL (US) | 2023-06-22 | — | — | WO | claimed |
| WO-2018191771-A1 | DETECTION AND TREATMENT OF CONGENITAL MALFORMATIONS | VICTOR CHANG CARDIAC RESEARCH INSTITUTE (AU) | 2018-10-25 | — | — | WO | claimed |
| EP-2164500-B1 | THE USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS | IDOGEN AB (SE) | 2013-12-04 | — | — | EP | claimed |
| US-6432683-B1 | Preparation of 2-aminomuconate from 2-aminophenol by coupled enzymatic dioxygenation and dehydrogenation reactions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2002-08-13 | — | — | US | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| EP-4658402-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | Centre National de la Recherche Scientifique (FR) | 2025-12-10 | — | — | EP | disclosed |
| CN-116635036-B | Nicotinamide mononucleotide derivatives and their use in the treatment and prevention of red blood cell disorders | 努瓦米德股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | disclosed |
| US-20250044306-A1 | Methods for Determining Opioid Responsiveness in the Treatment of Pain | EAST CAROLINA UNIVERSITY | 2025-02-06 | — | — | US | disclosed |
| WO-2024160984-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-08-08 | — | — | WO | disclosed |
| US-20070298484-A1 | Method and Device for Thermal Conditioning of a Cell | INSILICO BIOTECHNOLOGY GMBH (DE) | 2007-12-27 | — | — | US | disclosed |
| US-20060051782-A1 | Directed evolution of recombinant monooxygenase nucleic acids and related polypeptides and methods of use | UNIVERSITY OF CONNECTICUT | 2006-03-09 | — | — | US | disclosed |
| US-6432683-B1 | Preparation of 2-aminomuconate from 2-aminophenol by coupled enzymatic dioxygenation and dehydrogenation reactions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2002-08-13 | — | — | US | disclosed |
| US-6432683-B1 | Preparation of 2-aminomuconate from 2-aminophenol by coupled enzymatic dioxygenation and dehydrogenation reactions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2002-08-13 | — | — | US | disclosed |
| US-6432683-B1 | Preparation of 2-aminomuconate from 2-aminophenol by coupled enzymatic dioxygenation and dehydrogenation reactions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2002-08-13 | — | — | US | disclosed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | disclosed |